Under construction – not a live service
Sign in
Taking people in SpainNo phase

Comparing two ways to guide heart ablation for atrial fibrillation

Compares two guidance methods during balloon pulsed-field ablation in adults with atrial fibrillation.

Plain-language title generated from the registry record
Registry title: Comparison of Fluoroscopy-only vs. Electroanatomic Mapping Strategies for Pulmonary Vein Isolation With Balloon-based Pulsed-field Ablation

Key facts

Where
Madrid, SpainSee the site

Where in Spain

  • University Hospital 12 de OctubreMadrid, SpainTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Daniel Rodríguez Muñoz
Trial code
NCT07118046
Record updated
11 September 2025
Original description
We designed a study to evaluate the impact of a two systematic strategies for PVI with the octaspline, balloon-based PFA (B-PFA) catheter. We hypothesized that the addition of electroanatomic guidance is non-superior to fluoroscopy-only guidance in achieving durable PVI.Read full original descriptionShow less

Comparison of Fluoroscopy-only vs. Electroanatomic Mapping Strategies for Pulmonary Vein Isolation With Balloon-based Pulsed-field Ablation

We designed a study to evaluate the impact of a two systematic strategies for PVI with the octaspline, balloon-based PFA (B-PFA) catheter. We hypothesized that the addition of electroanatomic guidance is non-superior to fluoroscopy-only guidance in achieving durable PVI.

Inclusion: ≥18 years old; Diagnosed with paroxysmal or persistent AF; Clinical indication to undergo PVI.

Exclusion: Prior PVI or left atrial linear ablation; Congenital heart disease; Severe frailty or life expectancy <1 year; Unwillingness or inability to provide informed consent; Ablation at sites beyond PVI or indication for additional electrophysiological study; Contraindication or intolerance to heparin; Presence of left atrial thrombus; Pregnancy, ongoing or planned in the following 6 months.

ClinicalTrials.gov NCT07118046